Nephros INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ

14 Nov 2025

NEPH

SCHEDULE: Topline Capital Discloses 5.6% Stake in Nephros Inc.

Topline Capital Management, LLC, Collin McBirney, and Topline Capital Partners, LP have disclosed a 5.6% beneficial ownership stake in Nephros Inc. common stock.